Una Nattermann

Title: Innovations in Vaccine Development by Una Nattermann

Introduction

Una Nattermann is an accomplished inventor based in Seattle, WA. She has made significant contributions to the field of vaccine development, particularly through her innovative work on self-assembling nanostructure vaccines. Her research focuses on creating nanostructures that can effectively display antigens, eliciting immune responses to various infectious agents.

Latest Patents

Una Nattermann holds a patent for her groundbreaking invention titled "Self-assembling nanostructure vaccines." This patent describes nanostructures and nanostructure-based vaccines that display antigens capable of eliciting immune responses to infectious agents such as bacteria, viruses, and pathogens. The vaccines developed from her research are useful for preventing or decreasing the severity of infections, including diseases like Lyme disease, pertussis, herpes virus, and malaria. The antigens can be attached to the core of the nanostructure either non-covalently or covalently, and multimeric antigens may be displayed along the symmetry axis of the nanostructure.

Career Highlights

Una Nattermann is affiliated with the University of Washington, where she continues her research and development in the field of immunology and vaccine technology. Her work has garnered attention for its potential to revolutionize how vaccines are developed and administered.

Collaborations

Una has collaborated with notable researchers in her field, including Neil P King and David Baker. These collaborations have further enhanced the impact of her research and contributed to advancements in vaccine technology.

Conclusion

Una Nattermann's innovative work in the development of self-assembling nanostructure vaccines represents a significant advancement in the fight against infectious diseases. Her contributions to the field of immunology are paving the way for more effective vaccines and improved public health outcomes.